Therapeutic opportunities within the DNA damage response

Gene Ontology: tool for the unification of biology

Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206 · see citing works

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989 · see citing works

Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer

Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239 · see citing works

Comprehensive molecular portraits of human breast tumours

The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129 · see citing works

Gephi: An Open Source Software for Exploring and Manipulating Networks

Bastian, M., Heymann, S., & Jacomy, M. (2009) · Proceedings of the International AAAI Conference on Web and Social Media · doi:10.1609/icwsm.v3i1.13937 · Cited by 11,675 · see citing works

Signatures of mutational processes in human cancer

Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660 · see citing works

The cancer genome atlas pan-cancer analysis project

The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092 · see citing works

Comprehensive molecular characterization of human colon and rectal cancer

The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499 · see citing works

Integrated genomic analyses of ovarian carcinoma

Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927 · see citing works

Cancer Genome Landscapes

Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863 · see citing works

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735 · see citing works

Surfing the p53 network

Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · see citing works

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · see citing works

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia

The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078 · see citing works

Cytoscape 2.8: new features for data integration and network visualization

Smoot, M. E., Ono, K., Ruscheinski, J., Wang, P., & Ideker, T. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq675 · Cited by 4,770 · see citing works

STRING v9.1: protein-protein interaction networks, with increased coverage and integration

Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., von Mering, C., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1094 · Cited by 4,398 · see citing works

ChEMBL: a large-scale bioactivity database for drug discovery

Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382 · see citing works

Comprehensive genomic characterization of squamous cell lung cancers

The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994 · see citing works

Drug-like properties and the causes of poor solubility and poor permeability

Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,776 · see citing works

How many drug targets are there?

Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505 · see citing works

Comprehensive molecular characterization of clear cell renal cell carcinoma

The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485 · see citing works

A census of human cancer genes

Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184 · see citing works

Data, information, knowledge and principle: back to metabolism in KEGG

Kanehisa, M. I., Goto, S., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1076 · Cited by 3,103 · see citing works

Patterns of somatic mutation in human cancer genomes

Greenman, C. D., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G. R., Davies, H. R., Teague, J. W., Butler, A. P., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,062 · see citing works

Comprehensive molecular characterization of urothelial bladder carcinoma

Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/za09-dk57 · Cited by 2,992 · see citing works

Molecular mechanisms of cisplatin resistance

Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760 · see citing works

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278 · see citing works

The causes and consequences of genetic heterogeneity in cancer evolution

Burrell, R. A., McGranahan, N., Bartek, J., & Swanton, C. (2013) · Nature · doi:10.1038/nature12625 · Cited by 2,262 · see citing works

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · see citing works

An Oncogene-Induced DNA Damage Model for Cancer Development

Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851 · see citing works

The DNA damage response and cancer therapy

Lord, C. J., & Ashworth, A. (2012) · Nature · doi:10.1038/nature10760 · Cited by 1,843 · see citing works

Reactome: a database of reactions, pathways and biological processes

Croft, D., O'Kelly, G., Wu, G., Haw, R., Gillespie, M., Matthews, L., Caudy, M., Garapati, P., Gopinath, G., Jassal, B., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1018 · Cited by 1,751 · see citing works

The DNA Damage Response: Ten Years After

Harper, J. W., & Elledge, S. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.015 · Cited by 1,705 · see citing works

DNA repair pathways as targets for cancer therapy

Helleday, T., Petermann, E., Lundin, C., Hodgson, B., & Sharma, R. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2342 · Cited by 1,666 · see citing works

PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse

Hornbeck, P. V., Kornhauser, J. M., Tkachev, S., Zhang, B., Skrzypek, E., Murray, B. W., Latham, V. M., & Sullivan, M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1122 · Cited by 1,636 · see citing works

The Concept of Synthetic Lethality in the Context of Anticancer Therapy

Kaelin, W. G. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1691 · Cited by 1,369 · see citing works

Biallelic Inactivation of <i>BRCA2</i> in Fanconi Anemia

Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149 · see citing works

Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers

Pfeifer, G. P., Denissenko, M. F., Olivier, M., Tretyakova, N. Y., Hecht, S. S., & Hainaut, P. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205803 · Cited by 1,114 · see citing works

DNA repair dysregulation from cancer driver to therapeutic target

Curtin, N. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3399 · Cited by 1,051 · see citing works

The BioGRID interaction database: 2013 update

Chatr‐aryamontri, A., Breitkreutz, B., Heinicke, S., Boucher, L., Winter, A. G., Stark, C., Nixon, J., Ramage, L., Kolas, N. K., O’Donnell, L., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1158 · Cited by 1,010 · see citing works

EUKARYOTIC TRANSLESION SYNTHESIS DNA POLYMERASES: Specificity of Structure and Function

Prakash, S., Johnson, R. E., & Prakash, L. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133250 · Cited by 999 · see citing works

Temozolomide: Mechanisms of Action, Repair and Resistance

Zhang, J., Stevens, M. F. G., & Bradshaw, T. D. (2011) · Current Molecular Pharmacology · doi:10.2174/1874467211205010102 · Cited by 887 · see citing works

Cytoscape 2.8: new features for data integration and network

Smoot, E., Ono, K., Ruscheinski, J., Wang, P., & Ideker, T. E. (2011) · Cited by 791 · see citing works

Genetic instability and darwinian selection in tumours

Cahill, D. P., Kinzler, K. W., Vogelstein, B., & Christoph Lengauer, C. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01661-x · Cited by 747 · see citing works

Drugging the p53 pathway: understanding the route to clinical efficacy

Khoo, K. H., Verma, C. S., & Lane, D. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4236 · Cited by 723 · see citing works

The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance

Bouwman, P., & Jonkers, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3342 · Cited by 615 · see citing works

Regulation of DNA Damage Responses by Ubiquitin and SUMO

Jackson, S. P., & Durocher, D. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.017 · Cited by 601 · see citing works

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

Antoniou, A. C., Cunningham, A. P., Peto, J., Evans, D. G., Lalloo, F. I., Narod, S. A., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Southey, M. C., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604305 · Cited by 525 · see citing works

Mutational signatures: the patterns of somatic mutations hidden in cancer genomes

Alexandrov, L. B., & Stratton, M. R. (2014) · Current Opinion in Genetics &amp; Development · doi:10.1016/j.gde.2013.11.014 · Cited by 488 · see citing works

Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors

Lord, C. J., Tutt, A. N. J., & Ashworth, A. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-050913-022545 · Cited by 476 · see citing works

Replication and protection of telomeres

Verdun, R. E., & Karlseder, J. (2007) · Nature · doi:10.1038/nature05976 · Cited by 463 · see citing works

MEN and SIN: what's the difference?

Bardin, A. J., & Amon, A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099020 · Cited by 344 · see citing works

Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor

Barber, L. J., Sandhu, S. K., Chen, L., Campbell, J., Kozarewa, I., Fenwick, K., Assiotis, I., Rodrigues, D. N., Reis-Filho, J. S., Moreno, V., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4140 · Cited by 337 · see citing works

A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor

Turner, N. C., Lord, C. J., Iorns, E. J., Brough, R., Swift, S., Elliott, R. J. R., Rayter, S., Tutt, A. N. J., & Ashworth, A. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.61 · Cited by 322 · see citing works

NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling

Lindström, M. S. (2011) · Biochemistry Research International · doi:10.1155/2011/195209 · Cited by 308 · see citing works

Factors underlying sensitivity of cancers to small-molecule kinase inhibitors

Janne, P. A., Gray, N. S., & Settleman, J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2871 · Cited by 303 · see citing works

Integrated analysis of germline and somatic variants in ovarian cancer

Kanchi, K., Johnson, K. J., Lu, C., McLellan, M. D., Leiserson, M. D. M., Wendl, M. C., Zhang, Q., Koboldt, D. C., Xie, M., Kandoth, C., et al. (2014) · Nature Communications · doi:10.1038/ncomms4156 · Cited by 294 · see citing works

Tankyrase-targeted therapeutics: expanding opportunities in the PARP family

Riffell, J. L., Lord, C. J., & Ashworth, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3868 · Cited by 290 · see citing works

A selective USP1–UAF1 inhibitor links deubiquitination to DNA damage responses

Liang, Q., Dexheimer, T. S., Zhang, P., Rosenthal, A. S., Villamil, M. A., You, C., Zhang, Q., Chen, J., Ott, C. A., Sun, H., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1455 · Cited by 264 · see citing works

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

Bancroft, E. K., Page, E. C., Castro, E., Lilja, H. G., Vickers, A. J., Sjoberg, D. D., Assel, M. J., Foster, C. S., Mitchell, G., Drew, K., et al. (2014) · European Urology · doi:10.1016/j.eururo.2014.01.003 · Cited by 253 · see citing works

Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses

Kuhn, E., Wu, R., Guan, B., Wu, G., Zhang, J., Wang, Y., Song, L., Yuan, X., Wei, L., Roden, R. B. S., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs345 · Cited by 249 · see citing works

Mapping the Cancer Genome

Collins, F. S., & Barker, A. D. (2007) · Scientific American · doi:10.1038/scientificamerican0307-50 · Cited by 231 · see citing works

Mutations in UVSSA cause UV-sensitive syndrome and impair RNA polymerase IIo processing in transcription-coupled nucleotide-excision repair

Nakazawa, Y., Sasaki, K., Mitsutake, N., Matsuse, M., Shimada, M., Nardò, T., Takahashi, Y., Ohyama, K., Ito, K., Mishima, H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2229 · Cited by 213 · see citing works

DNA Polymerases as Potential Therapeutic Targets for Cancers Deficient in the DNA Mismatch Repair Proteins MSH2 or MLH1

Martin, S. A., McCabe, N., Mullarkey, M. J., Cummins, R., Burgess, D. J., Nakabeppu, Y., Oka, S., Kay, E. W., Lord, C. J., & Ashworth, A. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.046 · Cited by 201 · see citing works

USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.

Fan, Y.-H., Cheng, J., Vasudevan, S. A., Dou, J., Zhang, H., Patel, R. H., Ma, I. T., Rojas, Y., Zhao, Y., Yu, Y., et al. (2013) · Cell Death &amp; Disease · doi:10.1038/cddis.2013.400 · Cited by 199 · see citing works

DNA repair: From molecular mechanism to human disease

Friedberg, E. C., Aguilera, A., Gellert, M. F., Hanawalt, P. C., Hays, J. B., Lehmann, A. R., Lindahl, T. L., Lowndes, N. F., Sarasin, A. R., & Wood, R. D. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.005 · Cited by 193 · see citing works

Structural basis for recruitment of BRCA2 by PALB2

Oliver, A. W., Swift, S., Lord, C. J., Ashworth, A., & Pearl, L. H. (2009) · EMBO Reports · doi:10.1038/embor.2009.126 · Cited by 181 · see citing works

Structure-based druggability assessment — identifying suitable targets for small molecule therapeutics

Fauman, E. B., Rai, B. K., & Huang, E. S. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.05.020 · Cited by 178 · see citing works

Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies.

Collins, F. S., & Barker, A. D. (2007) · PubMed · Cited by 176 · see citing works

A Small Molecule Inhibitor of the BLM Helicase Modulates Chromosome Stability in Human Cells

Nguyen, G. H., Dexheimer, T. S., Rosenthal, A. S., Chu, W. K., Singh, D. K., Mosedale, G., Bachrati, C. Z., Schultz, L., Sakurai, M., Savitsky, P. A., et al. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.10.016 · Cited by 169 · see citing works

Non-homologous DNA end joining.

Pastwa, E., & Błasiak, J. (2003) · Acta Biochimica Polonica · doi:10.18388/abp.2003_3622 · Cited by 163 · see citing works

Systematic characterization of deubiquitylating enzymes for roles in maintaining genome integrity

Nishi, R., Wijnhoven, P. W. G., le Sage, C., Tjeertes, J., Galanty, Y., Forment, J. V., Clague, M. J., Urbé, S., & Jackson, S. P. (2014) · Nature Cell Biology · doi:10.1038/ncb3028 · Cited by 148 · see citing works

canSAR: an updated cancer research and drug discovery knowledgebase

Tym, J. E., Mitsopoulos, C., Coker, E. A., Razaz, P., Schierz, A. C., Antolín, A. A., & Al‐Lazikani, B. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1030 · Cited by 135 · see citing works

Objective assessment of cancer genes for drug discovery

Patel, M. N., Halling‐Brown, M., Tym, J. E., Workman, P., & Al‐Lazikani, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3913 · Cited by 130 · see citing works

Integrated genomic analyses of ovarian carcinoma

The Cancer Genome Atlas Research Network (2011) · Nature · doi:10.1038/nature10166 · Cited by 129 · see citing works

Smc5/6: a link between DNA repair and unidirectional replication?

Murray, J. M., & Carr, A. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2309 · Cited by 113 · see citing works

SnapShot: DNA Mismatch Repair

Larrea, A. A., Lujan, S. A., & Kunkel, T. A. (2010) · Cell · doi:10.1016/j.cell.2010.05.002 · Cited by 106 · see citing works

Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities

Landré, V., Rotblat, B., Melino, S., Bernassola, F., & Melino, G. (2014) · Oncotarget · doi:10.18632/oncotarget.2431 · Cited by 105 · see citing works

Searching for synthetic lethality in cancer

Brough, R., Frankum, J. R., Costa-Cabral, S., Lord, C. J., & Ashworth, A. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.009 · Cited by 104 · see citing works

The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase

Franchitto, A., Pichierri, P., Piergentili, R., Crescenzi, M., Bignami, M., & Palitti, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206254 · Cited by 102 · see citing works

Familial pancreatic cancer: genetic advancesPreprint

Rustgi, A. K. (2014) · Genes & Development · doi:10.1101/gad.228452.113 · Cited by 101 · see citing works

Chromosome Segregation in Budding Yeast: Sister Chromatid Cohesion and Related Mechanisms

Marston, A. L. (2014) · Genetics · doi:10.1534/genetics.112.145144 · Cited by 95 · see citing works

Deubiquitylating Enzymes and DNA Damage Response Pathways

Jacq, X., Kemp, M. I., Martin, N. M. B., & Jackson, S. P. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9635-3 · Cited by 90 · see citing works

An Evolutionarily Conserved Synthetic Lethal Interaction Network Identifies FEN1 as a Broad-Spectrum Target for Anticancer Therapeutic Development

van Pel, D. M., Barrett, I. J., Shimizu, Y., Sajesh, B. V., Guppy, B. J., Pfeifer, T., McManus, K. J., & Hieter, P. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003254 · Cited by 89 · see citing works

Breast Cancer Proteins PALB2 and BRCA2 Stimulate Polymerase η in Recombination-Associated DNA Synthesis at Blocked Replication Forks

Buisson, R., Joshi, N., Pauty, J., Maity, R., Zhao, W., Coulombe, Y., Sung, P., & Masson, J. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.01.009 · Cited by 88 · see citing works

Polo-like kinase 1 as target for cancer therapy

Weiß, L., & Efferth, T. (2012) · Experimental Hematology and Oncology · doi:10.1186/2162-3619-1-38 · Cited by 84 · see citing works

canSAR: updated cancer research and drug discovery knowledgebase

Bulusu, K. C., Tym, J. E., Coker, E. A., Schierz, A. C., & Al‐Lazikani, B. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1182 · Cited by 74 · see citing works

DNA Repair in Mammalian Cells

Eker, A. P. M., Quayle, C., Chaves, I., & van der Horst, G. T. J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8735-0 · Cited by 72 · see citing works

Definition of the intermediates and mechanism of the anticancer drug bleomycin using nuclear resonance vibrational spectroscopy and related methods

Liu, L. V., Bell, C. B., Wong, S. D., Wilson, S. A., Kwak, Y., Chow, M. S., Zhao, J. Y., Hodgson, K. O., Hedman, B., & Solomon, E. I. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016323107 · Cited by 72 · see citing works

Aurora kinases in head and neck cancer

Mehra, R., Serebriiskii, I. G., Burtness, B. A., Astsaturov, I. A., & Golemis, E. A. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70128-1 · Cited by 72 · see citing works

A Single-Nucleotide Substitution Mutator Phenotype Revealed by Exome Sequencing of Human Colon Adenomas

Nikolaev, S. I., Sotiriou, S. K., Pateras, I. S., Santoni, F. A., Sougioultzis, S., Edgren, H., Almusa, H., Robyr, D., Guipponi, M., Saarela, J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-3869 · Cited by 69 · see citing works

APRIN is a cell cycle specific BRCA2‐interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer

Brough, R., Bajrami, I., Vatcheva, R., Natrajan, R., Reis-Filho, J. S., Lord, C. J., & Ashworth, A. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.490 · Cited by 68 · see citing works

Cancer chromosomes going to POT1

Chang, S. S. (2013) · Nature Genetics · doi:10.1038/ng.2617 · Cited by 64 · see citing works

Targeting an Achilles’ heel of cancer with a WRN helicase inhibitor

Aggarwal, M., Banerjee, T., Sommers, J. A., & Brosh, R. M. (2013) · Cell Cycle · doi:10.4161/cc.26320 · Cited by 62 · see citing works

DNA ligases as therapeutic targets.

Tomkinson, A. E., Howes, T. R. L., & Wiest, N. E. (2013) · PubMed · Cited by 60 · see citing works

Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology

Workman, P., Al‐Lazikani, B., & Clarke, P. A. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.06.004 · Cited by 58 · see citing works

DNA End-Processing Enzyme Polynucleotide Kinase As a Potential Target in the Treatment of Cancer

Allinson, S. L. (2010) · Future Oncology · doi:10.2217/fon.10.40 · Cited by 56 · see citing works

Deubiquitinating Enzymes as Therapeutic Targets in Cancer

Lim, K., & Baek, K. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319220013 · Cited by 54 · see citing works

Complementary non-radioactive assays for investigation of human flap endonuclease 1 activity

Dorjsuren, D. G., Kim, D., Maloney, D. J., Wilson, D. M., & Simeonov, A. M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1082 · Cited by 54 · see citing works

MoKCa database—mutations of kinases in cancer

Richardson, C. J., Gao, Q., Mitsopoulous, C., Zvelebil, M., Pearl, L. H., & Pearl, F. M. G. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn832 · Cited by 51 · see citing works

Investigations of homologous recombination pathways and their regulation.

Daley, J. M., Kwon, Y., Niu, H., & Sung, P. (2013) · Europe PMC (PubMed Central) · Cited by 46 · see citing works

The RSC and INO80 Chromatin-Remodeling Complexes in DNA Double-Strand Break Repair

Chambers, A. L., & Downs, J. A. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-387665-2.00009-2 · Cited by 45 · see citing works

Analysis of the gene coding for the BRCA2‐Interacting protein PALB2 in hereditary prostate cancer

Tischkowitz, M. D., Sabbaghian, N., Ray, A. M., Lange, E. M., Foulkes, W. D., & Cooney, K. A. (2008) · The Prostate · doi:10.1002/pros.20729 · Cited by 41 · see citing works

Saccharomyces cerevisiaeGenetics Predicts Candidate Therapeutic Genetic Interactions at the Mammalian Replication Fork

van Pel, D. M., Stirling, P. C., Minaker, S. W., Sipahimalani, P., & Hieter, P. (2013) · G3 Genes Genomes Genetics · doi:10.1534/g3.112.004754 · Cited by 37 · see citing works

Amino Acid Asp181 of 5′-Flap Endonuclease 1 Is a Useful Target for Chemotherapeutic Development

Panda, H., Jaiswal, A. S., Corsino, P. E., Armas, M. L., Law, B. K., & Narayan, S. (2009) · Biochemistry · doi:10.1021/bi9010754 · Cited by 36 · see citing works

Fanconi anemia: a signal transduction and DNA repair pathway.

Kupfer, G. M. (2013) · Europe PMC (PubMed Central) · Cited by 33 · see citing works

Building high-resolution synthetic lethal networks: a ‘Google map’ of the cancer cell

Paul, J., Templeton, S. D., Baharani, A., Freywald, A., & Vizeacoumar, F. J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.09.009 · Cited by 32 · see citing works

Synthetic Lethal Targeting of PTEN-Deficient Cancer Cells Using Selective Disruption of Polynucleotide Kinase/Phosphatase

Mereniuk, T. R., Gendy, M. A. M. E., Mendes‐Pereira, A. M., Lord, C. J., Ghosh, S., Foley, E., Ashworth, A., & Weinfeld, M. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1093 · Cited by 30 · see citing works

Molecular Mechanism of Base Excision Repair of Uracil-containing DNA in Yeast Cell-free Extracts

Wang, Z., Wu, X., & Friedberg, E. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.24064 · Cited by 29 · see citing works

Development of a High-Throughput Fluorescence Polarization DNA Cleavage Assay for the Identification of FEN1 Inhibitors

McWhirter, C. L., Tonge, M. E., Plant, H., Hardern, I. M., Nissink, J. W. M., & Durant, S. T. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113476551 · Cited by 25 · see citing works

Deriving a Mutation Index of Carcinogenicity Using Protein Structure and Protein Interfaces

Espinosa, O., Mitsopoulos, K., Hakas, J., Pearl, F. M. G., & Zvelebil, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084598 · Cited by 22 · see citing works

Recessive cancer genes engage in negative genetic interactions with their functional paralogs.

D'Antonio, M., Guerra, R., Cereda, M., Marchesi, S., Montani, F., Nicassio, F., Fiore, P. D., & Ciccarelli, F. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.033 · Cited by 17 · see citing works

DNA Repair: Nucleotide excision–repair in the test tube

Jaspers, N. G. J., & Hoeijmakers, J. H. J. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00137-0 · Cited by 5 · see citing works

Pan-cancer analysis of whole genomes

The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Aaltonen, L. A., Abascal, F., Abeshouse, A., Aburatani, H., Adams, D. J., Agrawal, N., Ahn, K. S., Ahn, S.-M., Aikata, H., et al. (2020) · Nature · doi:10.1038/s41586-020-1969-6 · Cited by 3,064 · see citing works

Targeting the DNA Damage Response in Cancer

O’Connor, M. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.040 · Cited by 1,551 · see citing works

Cell cycle control in cancer

Matthews, H. K., Bertoli, C., & de Bruin, R. A. M. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00404-3 · Cited by 1,506 · see citing works

Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

Knijnenburg, T., Wang, L., Zimmermann, M. T., Chambwe, N., Gao, G. F., Cherniack, A. D., Fan, H., Shen, H., Way, G. P., Greene, C. S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.076 · Cited by 1,126 · see citing works

DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy

Huang, R., & Zhou, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00648-7 · Cited by 948 · see citing works

Revisiting the hallmarks of cancer.

Fouad, Y. A., & Aanei, C. M. (2017) · Europe PMC (PubMed Central) · Cited by 873 · see citing works

DNA repair, genome stability and cancer: a historical perspective

Jeggo, P. A., Pearl, L. H., & Carr, A. M. (2015) · Nature reviews. Cancer · doi:10.1038/nrc.2015.4 · Cited by 764 · see citing works

CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset

Lee, J., Correia, K., Loupe, J. M., Kim, K., Barker, D., Hong, E. P., Chao, M. J., Long, J. D., Lucente, D. E., Vonsattel, J. P., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.036 · Cited by 532 · see citing works

Overcoming cancer therapeutic bottleneck by drug repurposing

Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 521 · see citing works

Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis

Reiter, R. J., Rosales‐Corral, S., Tan, D., Acuña-Castroviejo, D., Qin, L., Yang, S., & Xu, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040843 · Cited by 446 · see citing works

Genetic Insights Into Biological Mechanisms Governing Human Ovarian Ageing

Ruth, K. S., Day, F. R., Hussain, J., Martínez-Marchal, A., Aiken, C., Azad, A., Thompson, D. J., Knoblochová, L., Abe, H., Tarry‐Adkins, J. L., et al. (2021) · Nature · doi:10.1038/s41586-021-03779-7 · Cited by 436 · see citing works

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance

Secrier, M., Li, X., de Silva, N., Eldridge, M., Contino, G., Bornschein, J., MacRae, S., Grehan, N., O’Donovan, M., Miremadi, A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3659 · Cited by 397 · see citing works

DNA Repair Pathways in Cancer Therapy and Resistance

Li, L.-Y., Guan, Y.-D., Chen, X.-S., Yang, J.-M., & Cheng, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.629266 · Cited by 383 · see citing works

Lifestyle and dietary environmental factors in colorectal cancer susceptibility

Murphy, N., Moreno, V. R., Hughes, D. J., Vodicka, L., Vodička, P., Aglago, E. K., Gunter, M. J., & Jenab, M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.06.005 · Cited by 320 · see citing works

Tumour treating fields therapy for glioblastoma: current advances and future directions

Rominiyi, O., Vanderlinden, A., Clenton, S. J., Bridgewater, C. H., Al-Tamimi, Y., & Collis, S. J. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01136-5 · Cited by 319 · see citing works

Report of the AAPM TG ‐256 on the relative biological effectiveness of proton beams in radiation therapy

Paganetti, H., Blakely, E. A., Cárabe, A., Carlson, D. J., Das, I. J., Dong, L., Grosshans, D. R., Held, K. D., Mohan, R., Moiseenko, V., et al. (2019) · Medical Physics · doi:10.1002/mp.13390 · Cited by 318 · see citing works

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

Moss, D. J. H., Pardiñas, A. F., Langbehn, D., Lo, K., Leavitt, B. R., Roos, R., Durr, A., Mead, S., Coleman, A., Santos, R. D., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30161-8 · Cited by 312 · see citing works

Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease

Kalimutho, M., Parsons, K., Mittal, D., López, J. A., Srihari, S., & Khanna, K. K. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.08.009 · Cited by 289 · see citing works

Genetic etiology of oral cancer

Ali, J., Sabiha, B., Jan, H., Haider, S. A., Khan, A. A., & Ali, S. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.05.004 · Cited by 264 · see citing works

Homologous recombination deficiency and ovarian cancer

Ledermann, J. A., Drew, Y., & Kristeleit, R. S. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.03.005 · Cited by 258 · see citing works

MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment

Bian, L., Meng, Y., Zhang, M., & Li, D. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1100-5 · Cited by 253 · see citing works

Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs

Hadi, K., Yao, X., Behr, J. M., Deshpande, A. S., Xanthopoulakis, C., Tian, H., Kudman, S., Rosiene, J. A., Darmofal, M., DeRose, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.006 · Cited by 249 · see citing works

An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy

Wang, Y.-Q., Wang, P., Wang, Y.-T., Yang, G., Zhang, A., & Miao, Z. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00055 · Cited by 248 · see citing works

ATM in DNA repair in cancer

Jin, M. H., & Oh, D. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.07.002 · Cited by 246 · see citing works

Mutational signatures are jointly shaped by DNA damage and repair

Volkova, N. V., Meier, B., González‐Huici, V., Bertolini, S., González, S., Vöhringer, H. S., Abascal, F., Martincorena, I., Campbell, P. J., Gartner, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15912-7 · Cited by 223 · see citing works

Human female meiosis revised: new insights into the mechanisms of chromosome segregation and aneuploidies from advanced genomics and time-lapse imaging

Capalbo, A., Hoffmann, E. R., Cimadomo, D., Ubaldi, F. M., & Rienzi, L. F. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx026 · Cited by 221 · see citing works

STING enhances cell death through regulation of reactive oxygen species and DNA damage

Hayman, T. J., Baro, M., MacNeil, T., Phoomak, C., Aung, T. N., Cui, W., Leach, K., Iyer, R. P., Challa, S., Sandoval-Schaefer, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22572-8 · Cited by 210 · see citing works

Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy

Gourley, C., Balmañà, J., Ledermann, J. A., Serra, V., Dent, R. A., Loibl, S., Pujade-Lauraine, É., & Boulton, S. J. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02050 · Cited by 193 · see citing works

Regulated cell death and adaptive stress responses

Galluzzi, L., Bravo-San Pedro, J. M., Kepp, O., & Kroemer, G. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2209-y · Cited by 177 · see citing works

DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities

Jurkovičová, D., Neophytou, C. M., Gašparović, A. Č., & Gonçalves, A. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314672 · Cited by 170 · see citing works

Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy

Xu, Y., & Her, C. (2015) · Biomolecules · doi:10.3390/biom5031652 · Cited by 164 · see citing works

Melatonin: A pleiotropic molecule that modulates DNA damage response and repair pathways

Majidinia, M., Sadeghpour, A., Mehrzadi, S., Reiter, R. J., Khatami, N., & Yousefi, B. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12416 · Cited by 164 · see citing works

DeepSMILE: Contrastive self-supervised pre-training benefits MSI and HRD classification directly from H&E whole-slide images in colorectal and breast cancer

Schirris, Y., Gavves, E., Nederlof, I., Horlings, H. M., & Teuwen, J. (2022) · Medical Image Analysis · doi:10.1016/j.media.2022.102464 · Cited by 164 · see citing works

Evaluating the molecule-based prediction of clinical drug responses in cancer

Ding, Z., Zu, S., & Gu, J. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw344 · Cited by 155 · see citing works

The RNA Splicing Response to DNA Damage

Shkreta, L., & Chabot, B. (2015) · Biomolecules · doi:10.3390/biom5042935 · Cited by 154 · see citing works

A new wave of innovations within the DNA damage response

Li, Q., Qian, W., Zhang, Y., Hu, L., Chen, S., & Xia, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01548-8 · Cited by 152 · see citing works

Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies

Davalli, P., Marverti, G., Lauriola, A., & D’Arca, D. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2389523 · Cited by 151 · see citing works

Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics

Antao, A. M., Tyagi, A., Kim, K.-S., & Ramakrishna, S. (2020) · Cancers · doi:10.3390/cancers12061579 · Cited by 150 · see citing works

DNA damage response and resistance of cancer stem cells

Abad, E., Graifer, D., & Lyakhovich, A. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.008 · Cited by 146 · see citing works

Targeted Therapies for Ovarian Cancer

Grunewald, T., & Ledermann, J. A. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.12.001 · Cited by 145 · see citing works

The molecular landscape of ETMR at diagnosis and relapse

Lambo, S., Gröbner, S. N., Rausch, T., Waszak, S. M., Schmidt, C., Gorthi, A., Romero, J. C., Mauermann, M., Brabetz, S., Krausert, S., et al. (2019) · Nature · doi:10.1038/s41586-019-1815-x · Cited by 143 · see citing works

A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance

Wang, Z., Xu, Z., & Zhu, G. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201608936 · Cited by 141 · see citing works

Targeting DNA damage repair in small cell lung cancer and the biomarker landscape

Sen, T., Gay, C. M., & Byers, L. A. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.02.03 · Cited by 137 · see citing works

canSAR: an updated cancer research and drug discovery knowledgebase

Tym, J. E., Mitsopoulos, C., Coker, E. A., Razaz, P., Schierz, A. C., Antolín, A. A., & Al‐Lazikani, B. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1030 · Cited by 135 · see citing works

Bioinformatics in translational drug discovery

Wooller, S. K., Benstead-Hume, G., Chen, X., Ali, Y., & Pearl, F. M. G. (2017) · Bioscience Reports · doi:10.1042/bsr20160180 · Cited by 134 · see citing works

Variant classification in precision oncology

Leichsenring, J., Horak, P., Kreutzfeldt, S., Heining, C., Christopoulos, P., Volckmar, A., Neumann, O., Kirchner, M., Ploeger, C., Budczies, J., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32358 · Cited by 130 · see citing works

Role of Rad51 and DNA repair in cancer: A molecular perspective

Laurini, E., Marson, D., Fermeglia, A., Aulić, S., Fermeglia, M., & Pricl, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107492 · Cited by 128 · see citing works

Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic

Cerrato, A., Morra, F., & Celetti, A. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0456-2 · Cited by 127 · see citing works

CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair

Shenoy, T., Boysen, G., Wang, M. Y., Xu, Q. Z., Guo, W., Koh, F. M., Wang, C., Zhang, L. Z., Wang, Y., Gil, V., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx165 · Cited by 125 · see citing works

canSAR: update to the cancer translational research and drug discovery knowledgebase

Coker, E. A., Mitsopoulos, C., Tym, J. E., Komianou, A., Kannas, C. C., Micco, P. D., Villasclaras-Fernández, E. D., Özer, B., Antolín, A. A., Workman, P., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1129 · Cited by 121 · see citing works

The crosstalk between Wnt/β-catenin signaling pathway with DNA damage response and oxidative stress: Implications in cancer therapy

Karimian, A., Majidinia, M., Baghi, H. B., & Yousefi, B. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.01.003 · Cited by 120 · see citing works

Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients

Wang, C., Yin, R. H., Dai, J., Gu, Y., Cui, S., Ma, H., Zhang, Z., Huang, J., Qin, N., Jiang, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04492-2 · Cited by 115 · see citing works

Targeting DNA repair, DNA metabolism and replication stress as anti‐cancer strategies

Puigvert, J. C., Sanjiv, K., & Helleday, T. (2015) · FEBS Journal · doi:10.1111/febs.13574 · Cited by 114 · see citing works

Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis

Su, D., Ma, S., Shan, L., Wang, Y., Wang, Y., Cao, C., Liu, B., Yang, C., Wang, L., Tian, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120518 · Cited by 114 · see citing works

The rise and fall of poly(ADP-ribose): An enzymatic perspective

Pascal, J. M., & Ellenberger, T. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.04.008 · Cited by 107 · see citing works

Repair of 8-oxoG:A mismatches by the MUTYH glycosylase: Mechanism, metals and medicine

Banda, D. M., Nuñez, N. N., Burnside, M. A., Bradshaw, K. M., & David, S. S. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.008 · Cited by 103 · see citing works

Stress management by autophagy: Implications for chemoresistance

Huang, Z., Zhou, L., Chen, Z., Nice, E. C., & Huang, C. (2016) · International Journal of Cancer · doi:10.1002/ijc.29990 · Cited by 101 · see citing works

Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action

Khoury, A., Deo, K. M., & Aldrich-Wright, J. R. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2020.111070 · Cited by 100 · see citing works

DNA repair in the trinucleotide repeat disorders

Jones, L., Houlden, H., & Tabrizi, S. J. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30350-7 · Cited by 99 · see citing works

Tyrosyl–DNA phosphodiesterases: rescuing the genome from the risks of relaxation

Kawale, A. S., & Povirk, L. F. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1219 · Cited by 99 · see citing works

CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells

Manic, G., Signore, M., Sistigu, A., Russo, G., Corradi, F., Siteni, S., Musella, M., Vitale, S., De Angelis, M. L., Pallocca, M., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-312623 · Cited by 98 · see citing works

Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics

Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97 · see citing works

SIRT6 coordinates with CHD4 to promote chromatin relaxation and DNA repair

Hou, T., Cao, Z., Zhang, J., Tang, M., Tian, Y., Li, Y., Lu, X., Chen, Y., Wang, H., Wei, F., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa006 · Cited by 96 · see citing works

The central role of DNA damage and repair in CAG repeat diseases

Massey, T. H., & Jones, L. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031930 · Cited by 95 · see citing works

Genomic signatures reveal DNA damage response deficiency in colorectal cancer brain metastases

Sun, J., Wang, C., Zhang, Y., Xu, L., Fang, W. J., Zhu, Y., Zheng, Y., Chen, X., Xie, X., Hu, X., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10987-3 · Cited by 94 · see citing works

canSAR: update to the cancer translational research and drug discovery knowledgebase

Mitsopoulos, C., Micco, P. D., Villasclaras-Fernández, E. D., Dolciami, D., Holt, E., Mica, I. L., Coker, E. A., Tym, J. E., Campbell, J., Che, K. H., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1059 · Cited by 94 · see citing works

Deficiency of nucleotide excision repair is associated with mutational signature observed in cancerPreprint

Jager, M., Blokzijl, F., Kuijk, E., Bertl, J., Vougioukalaki, M., Janssen, R., Besselink, N. J. M., Boymans, S., de Ligt, J., Pedersen, J. S., et al. (2019) · Genome Research · doi:10.1101/gr.246223.118 · Cited by 94 · see citing works

Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers

Nones, K., Johnson, J., Newell, F., Patch, A. M., Thorne, H., Kazakoff, S. H., de Luca, X. M., Parsons, M. T., Ferguson, K., Reid, L. E., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz132 · Cited by 93 · see citing works

Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies

Molinaro, C., Martoriati, A., & Cailliau, K. (2021) · Cancers · doi:10.3390/cancers13153819 · Cited by 93 · see citing works

Genotoxic stress triggers the activation of IRE1α-dependent RNA decay to modulate the DNA damage response

Dufey, E., Pedro, J. M. B., Eggers, C., González-Quiroz, M., Urra, H., Sagredo, A. I., Sepúlveda, D., Pihán, P., Carreras‐Sureda, A., Hazari, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15694-y · Cited by 92 · see citing works

DNA repair and damage pathways in breast cancer development and therapy

Majidinia, M., & Yousefi, B. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.03.009 · Cited by 91 · see citing works

The Future of Radiobiology

Kirsch, D. G., Diehn, M., Kesarwala, A. H., Maity, A. M., Morgan, M. A., Schwarz, J. K., Bristow, R. G., Demaria, S., Eke, I., Griffin, R. J., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx231 · Cited by 91 · see citing works

DNA damage responses in cancer stem cells: Implications for cancer therapeutic strategies

Wang, Q. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i3.57 · Cited by 90 · see citing works

Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer

Xiao, L., Lan, X., Shi, X., Zhao, K., Wang, D., Wang, X., Li, F., Huang, H., & Liu, J. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.210 · Cited by 89 · see citing works

Cell cycle dysregulation in cancer

Glaviano, A., Singh, S. K., Lee, E. H. C., Okina, E., Lam, H. Y., Carbone, D., Reddy, E. P., O’Connor, M. J., Koff, A., Singh, G., et al. (2024) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100030 · Cited by 88 · see citing works

Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non–Small-Cell Lung Cancer

Zhang, K., Keymeulen, S., Nelson, R. A., Tong, T. R. S.-W., Yuan, Y., Yun, X., Liu, Z., Lopez, J., Raz, D. J., & Kim, J. Y. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.09.011 · Cited by 87 · see citing works

Polyphenols: Major regulators of key components of DNA damage response in cancer

Majidinia, M., Bishayee, A., & Yousefi, B. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102679 · Cited by 87 · see citing works

The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033

Bady, P., Kurscheid, S., Delorenzi, M., Gorlia, T., van den Bent, M. J., Hoang‐Xuan, K., Vauléon, É., Gijtenbeek, A., Enting, R. H., Thiessen, B. A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1810-6 · Cited by 86 · see citing works

DNA Damage Response and Repair Pathway Alteration and Its Association With Tumor Mutation Burden and Platinum-Based Chemotherapy in SCLC

Park, S., Lee, H., Lee, B., Lee, S., Sun, J., Park, W., Ahn, J. S., Ahn, M., & Park, K. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.05.014 · Cited by 86 · see citing works

Synthetic Lethality and Cancer – Penetrance as the Major Barrier

Ryan, C. J., Bajrami, I., & Lord, C. J. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.08.003 · Cited by 86 · see citing works

Multifunctional Magnetoliposomes for Sequential Controlled Release

Salvatore, A., Montis, C., Berti, D., & Baglioni, P. (2016) · ACS Nano · doi:10.1021/acsnano.6b03194 · Cited by 83 · see citing works

Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy

Babu, A., Muralidharan, R., Amreddy, N., Mehta, M., Munshi, A., & Ramesh, R. (2016) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2016.2621730 · Cited by 83 · see citing works

DNA damage response regulation by microRNAs as a therapeutic target in cancer

Majidinia, M., & Yousefi, B. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.09.003 · Cited by 82 · see citing works

MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?

Yang, H. K., Liu, Y., Chen, L., Zhao, J., Guo, M., Zhao, X., Wen, Z., He, Z., Chen, C., & Xu, L. (2023) · Biomolecules · doi:10.3390/biom13060877 · Cited by 81 · see citing works

Integrated multi-omics approach to distinct molecular characterization and classification of early-onset colorectal cancer

Du, M., Gu, D., Xin, J., Peters, U., Song, M., Cai, G., Li, S., Ben, S., Meng, Y., Chu, H., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100974 · Cited by 80 · see citing works

Targeting HDAC3, a new partner protein of AKT in the reversal of chemoresistance in acute myeloid leukemia via DNA damage response

Long, J., Fang, W. Y., Chang, L., Gao, W. H., Shen, Y., Jia, M. Y., Zhang, Y. X., Wang, Y., Dou, H. B., Zhang, W. J., et al. (2017) · Leukemia · doi:10.1038/leu.2017.130 · Cited by 78 · see citing works

Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer

Wiecek, A. J., Cutty, S. J., Kornai, D., Parreno-Centeno, M., Gourmet, L. E., Tagliazucchi, G. M., Jacobson, D. H., Zhang, P., Xiong, L., Bond, G. L., et al. (2023) · Genome biology · doi:10.1186/s13059-023-02963-4 · Cited by 78 · see citing works

Synthetic lethal strategies for the development of cancer therapeutics

Ngoi, N. Y. L., Gallo, D., Torrado, C., Nardo, M., Durocher, D., & Yap, T. A. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00966-z · Cited by 78 · see citing works

DNA damage response and repair in colorectal cancer: Defects, regulation and therapeutic implications

Mirza‐Aghazadeh‐Attari, M., Darband, S. G., Kaviani, M., Mihanfar, A., Aghazadeh-Attari, J., Yousefi, B., & Majidinia, M. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.07.005 · Cited by 77 · see citing works

Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies

Chen, R., Wang, G., Zheng, Y., Hua, Y., & Cai, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14064 · Cited by 76 · see citing works

The Effects of Localized Heat on the Hallmarks of Cancer

Hannon, G., Tansi, F. L., Hilger, I., & Prina‐Mello, A. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000267 · Cited by 76 · see citing works

Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors

Hahne, J. C., & Valeri, N. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00226 · Cited by 73 · see citing works

Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair

Ooki, A., Osumi, H., Yoshino, K., & Yamaguchi, K. (2024) · Gastric Cancer · doi:10.1007/s10120-024-01523-4 · Cited by 72 · see citing works

The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors

Wu, Z., Cui, P., Tao, H., Zhang, S., Ma, J., Liu, Z., Wang, J., Qian, Y., Chen, S., Huang, Z., et al. (2021) · Clinical Medicine Insights Oncology · doi:10.1177/1179554921996288 · Cited by 71 · see citing works

The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities

Green, A. M., & Weitzman, M. D. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102700 · Cited by 70 · see citing works

Genomic analysis of DNA repair genes and androgen signaling in prostate cancer

Jividen, K., Kedzierska, K., Yang, C., Szlachta, K. A., Ratan, A., & Paschal, B. M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4848-x · Cited by 67 · see citing works

Genetic modifiers of Mendelian disease: Huntington’s disease and the trinucleotide repeat disorders

Holmans, P., Massey, T. H., & Jones, L. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx261 · Cited by 65 · see citing works

Cdk5 links with DNA damage response and cancer

Liu, W., Li, J., Song, Y., Li, Y., Jia, Y., & Zhao, H. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0611-1 · Cited by 64 · see citing works

Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents

Kashyap, T., Argueta, C. E., Unger, T. J., Klebanov, B., Debler, S., Senapedis, W. T., Crochiere, M. L., Lee, M. S., Kauffman, M. G., Shacham, S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25637 · Cited by 64 · see citing works

CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin

Franco, S. D., Parrino, B., Gaggianesi, M., Pantina, V. D., Bianca, P., Nicotra, A., Mangiapane, L. R., Iacono, M. L., Ganduscio, G., Veschi, V., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102664 · Cited by 63 · see citing works

Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response

Das, S., Camphausen, K. A., & Shankavaram, U. T. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01136 · Cited by 14 · see citing works

Targeting the DNA damage response in cancer

Guffanti, F., Chiappa, M., & Damia, G. L. M. (2024) · MedComm · doi:10.1002/mco2.788 · Cited by 28 · see citing works

Targeting protein–protein interactions in the DNA damage response pathways for cancer chemotherapy

McPherson, K. S., & Korzhnev, D. M. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00101a · Cited by 33 · see citing works

DNA repair dysregulation from cancer driver to therapeutic target

Curtin, N. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3399 · Cited by 1,051 · see citing works

Targeting the key players of DNA Repair Pathways as Cancer Therapeutics

Roy, R. M., Garimella, S. V., & Pandrangi, S. L. (2022) · Research Journal of Biotechnology · doi:10.25303/1705rjbt203210 · Cited by 4 · see citing works